Grb7 family proteins and the insulin receptor for screening new medications
CA 2366277 C · Owner: Kasus-Jacobi, Anne · Inventors: Burnol, Anne-Francoise; Kasus-Jacobi, Anne; Bereziat, Veronique
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the use of Grb14 and homologous adapting proteins as tool for screening molecules designed for the treatment of diseases involving insulin. The invention also concerns a method for detecting molecules capable of modulating the tyrosine kinase activity of the insulin receptor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 14, 2000 and granted October 25, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 14, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 14, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.